APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025198 pages

Choose your research edition.

Industry ResearchChronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) include Abbott, Takeda, Fresenius, Amgen, Abbvie, Vifor, Spectrum, Shield and Sanofi Genzyme, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market size, projected growth trends, production technologies, key applications, and end-use industries.

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Company

Abbott

Takeda

Fresenius

Amgen

Abbvie

Vifor

Spectrum

Shield

Sanofi Genzyme

OPKO

Novadiol

Japan Tobacco Company

Daiichi-Sankyo

Astellas

Ardelyx

Akebia

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Type

Maintain Blood Calcium Levels

Control Hyperphosphatemia

Control PTH Level

Correct Acidosis

Others

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Application

Hospital Pharmacies

Drug Stores

Online Pharmacies

Retail Pharmacies

Others

Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Trends Table 2. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Drivers Table 3. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Opportunities and Challenges Table 4. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Restraints Table 5. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturers (tons) & (2021-2026) Table 8. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Manufacturers Table 9. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Sales Price (US$/kg) of Manufacturers (2021-2026) Table 10. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers, Product Type & Application Table 13. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Maintain Blood Calcium Levels Table 17. Major Manufacturers of Control Hyperphosphatemia Table 18. Major Manufacturers of Control PTH Level Table 19. Major Manufacturers of Correct Acidosis Table 20. Major Manufacturers of Others Table 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type 2021 VS 2025 VS 2032 (tons) Table 22. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2026) & (tons) Table 23. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2027-2032) & (tons) Table 24. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2021-2026) Table 25. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2027-2032) Table 26. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type 2021 VS 2025 VS 2032 (tons) Table 27. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2021-2026) & (tons) Table 28. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2027-2032) & (tons) Table 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2021-2026) Table 30. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Pharmacies Table 32. Major Manufacturers of Drug Stores Table 33. Major Manufacturers of Online Pharmacies Table 34. Major Manufacturers of Retail Pharmacies Table 35. Major Manufacturers of Others Table 36. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application 2021 VS 2025 VS 2032 (tons) Table 37. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2026) & (tons) Table 38. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2027-2032) & (tons) Table 39. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2021-2026) Table 40. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2027-2032) Table 41. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application 2021 VS 2025 VS 2032 (tons) Table 42. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2021-2026) & (tons) Table 43. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2027-2032) & (tons) Table 44. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2021-2026) Table 45. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2027-2032) Table 46. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 47. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2021-2026) & (tons) Table 48. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2021-2026) Table 49. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecasted by Region (2027-2032) & (tons) Table 50. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 52. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (tons) Table 53. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2027-2032) & (tons) Table 54. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 55. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (tons) Table 56. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2027-2032) & (tons) Table 57. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 58. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (tons) Table 59. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2027-2032) & (tons) Table 60. South America, Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 61. South America, Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2026) & (tons) Table 62. South America, Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2027-2032) & (tons) Table 63. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2021-2026) Table 67. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2027-2032) Table 68. Abbott Company Information Table 69. Abbott Business Overview Table 70. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 72. Abbott Recent Development Table 73. Takeda Company Information Table 74. Takeda Business Overview Table 75. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 77. Takeda Recent Development Table 78. Fresenius Company Information Table 79. Fresenius Business Overview Table 80. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 82. Fresenius Recent Development Table 83. Amgen Company Information Table 84. Amgen Business Overview Table 85. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 87. Amgen Recent Development Table 88. Abbvie Company Information Table 89. Abbvie Business Overview Table 90. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 92. Abbvie Recent Development Table 93. Vifor Company Information Table 94. Vifor Business Overview Table 95. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 97. Vifor Recent Development Table 98. Spectrum Company Information Table 99. Spectrum Business Overview Table 100. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 102. Spectrum Recent Development Table 103. Shield Company Information Table 104. Shield Business Overview Table 105. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 107. Shield Recent Development Table 108. Sanofi Genzyme Company Information Table 109. Sanofi Genzyme Business Overview Table 110. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 112. Sanofi Genzyme Recent Development Table 113. OPKO Company Information Table 114. OPKO Business Overview Table 115. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 117. OPKO Recent Development Table 118. Novadiol Company Information Table 119. Novadiol Business Overview Table 120. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 122. Novadiol Recent Development Table 123. Japan Tobacco Company Company Information Table 124. Japan Tobacco Company Business Overview Table 125. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 127. Japan Tobacco Company Recent Development Table 128. Daiichi-Sankyo Company Information Table 129. Daiichi-Sankyo Business Overview Table 130. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 132. Daiichi-Sankyo Recent Development Table 133. Astellas Company Information Table 134. Astellas Business Overview Table 135. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 137. Astellas Recent Development Table 138. Ardelyx Company Information Table 139. Ardelyx Business Overview Table 140. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 142. Ardelyx Recent Development Table 143. Akebia Company Information Table 144. Akebia Business Overview Table 145. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio Table 147. Akebia Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors List Table 151. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Image Figure 2. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size (2021-2032) & (US$ Million) Figure 4. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (2021-2032) & (tons) Figure 5. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Price (US$/kg) & (2021-2032) Figure 6. Global Top 5 and 10 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Maintain Blood Calcium Levels Image Figure 9. Control Hyperphosphatemia Image Figure 10. Control PTH Level Image Figure 11. Correct Acidosis Image Figure 12. Others Image Figure 13. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2021-2032) Figure 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2021 VS 2025 VS 2032) & (tons) Figure 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2021-2032) Figure 19. Hospital Pharmacies Image Figure 20. Drug Stores Image Figure 21. Online Pharmacies Image Figure 22. Retail Pharmacies Image Figure 23. Others Image Figure 24. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 25. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2021-2032) Figure 27. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2021 VS 2025 VS 2032) & (tons) Figure 28. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2021-2032) Figure 30. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 31. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2021-2032) Figure 32. U.S. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 33. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 34. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 35. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 36. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2021-2032) Figure 37. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 38. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 39. U.K. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 40. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 41. Netherlands Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 42. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 43. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2021-2032) Figure 44. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 45. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 46. South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 47. Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 48. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 49. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 50. South America, Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 51. South America, Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2021-2032) Figure 52. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 53. South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 54. Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 55. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 56. Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 57. UAE Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 58. Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 59. Chile Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Growth Rate (2021-2032) & (tons) Figure 60. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2021-2032) & (US$ Million) Figure 63. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2021-2032) & (US$ Million) Figure 65. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Maintain Blood Calcium Levels
  • Control Hyperphosphatemia
  • Control PTH Level
  • Correct Acidosis
  • Others
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Retail Pharmacies
  • Others
Companies covered
  • Abbott
  • Takeda
  • Fresenius
  • Amgen
  • Abbvie
  • Vifor
  • Spectrum
  • Shield
  • Sanofi Genzyme
  • OPKO
  • Novadiol
  • Japan Tobacco Company
  • Daiichi-Sankyo
  • Astellas
  • Ardelyx
  • Akebia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Dynamics
  1. 2.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Trends
  2. 2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Drivers
  3. 2.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Opportunities and Challenges
  4. 2.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Restraints
3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Manufacturers
  1. 3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers, Product Type & Application
  7. 3.7 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Tier 1, Tier 2, and Tier 3
4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Type
  1. 4.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type Introduction
  2. 4.1.1 Maintain Blood Calcium Levels
  3. 4.1.2 Control Hyperphosphatemia
  4. 4.1.3 Control PTH Level
  5. 4.1.4 Correct Acidosis
  6. 4.1.5 Others
  7. 4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type
  8. 4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2021-2032)
  10. 4.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2021-2032)
  11. 4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type
  12. 4.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2021-2032)
  14. 4.3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2021-2032)
5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Application
  1. 5.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.1.3 Online Pharmacies
  5. 5.1.4 Retail Pharmacies
  6. 5.1.5 Others
  7. 5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application
  8. 5.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2021-2032)
  10. 5.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2021-2032)
  11. 5.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application
  12. 5.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2021-2032)
  14. 5.3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2021-2032)
6 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region
  1. 6.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2021-2032)
  3. 6.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2021-2026)
  4. 6.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region
  1. 7.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region
  2. 7.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2021-2026)
  4. 7.1.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2027-2032)
  5. 7.1.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2021-2032)
  8. 7.2.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2021-2032)
  11. 7.3.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Takeda
  8. 8.2.1 Takeda Company Information
  9. 8.2.2 Takeda Business Overview
  10. 8.2.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  12. 8.2.5 Takeda Recent Developments
  13. 8.3 Fresenius
  14. 8.3.1 Fresenius Company Information
  15. 8.3.2 Fresenius Business Overview
  16. 8.3.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  18. 8.3.5 Fresenius Recent Developments
  19. 8.4 Amgen
  20. 8.4.1 Amgen Company Information
  21. 8.4.2 Amgen Business Overview
  22. 8.4.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  24. 8.4.5 Amgen Recent Developments
  25. 8.5 Abbvie
  26. 8.5.1 Abbvie Company Information
  27. 8.5.2 Abbvie Business Overview
  28. 8.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  30. 8.5.5 Abbvie Recent Developments
  31. 8.6 Vifor
  32. 8.6.1 Vifor Company Information
  33. 8.6.2 Vifor Business Overview
  34. 8.6.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  36. 8.6.5 Vifor Recent Developments
  37. 8.7 Spectrum
  38. 8.7.1 Spectrum Company Information
  39. 8.7.2 Spectrum Business Overview
  40. 8.7.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  42. 8.7.5 Spectrum Recent Developments
  43. 8.8 Shield
  44. 8.8.1 Shield Company Information
  45. 8.8.2 Shield Business Overview
  46. 8.8.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  48. 8.8.5 Shield Recent Developments
  49. 8.9 Sanofi Genzyme
  50. 8.9.1 Sanofi Genzyme Company Information
  51. 8.9.2 Sanofi Genzyme Business Overview
  52. 8.9.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  54. 8.9.5 Sanofi Genzyme Recent Developments
  55. 8.10 OPKO
  56. 8.10.1 OPKO Company Information
  57. 8.10.2 OPKO Business Overview
  58. 8.10.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  60. 8.10.5 OPKO Recent Developments
  61. 8.11 Novadiol
  62. 8.11.1 Novadiol Company Information
  63. 8.11.2 Novadiol Business Overview
  64. 8.11.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  66. 8.11.5 Novadiol Recent Developments
  67. 8.12 Japan Tobacco Company
  68. 8.12.1 Japan Tobacco Company Company Information
  69. 8.12.2 Japan Tobacco Company Business Overview
  70. 8.12.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  72. 8.12.5 Japan Tobacco Company Recent Developments
  73. 8.13 Daiichi-Sankyo
  74. 8.13.1 Daiichi-Sankyo Company Information
  75. 8.13.2 Daiichi-Sankyo Business Overview
  76. 8.13.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  78. 8.13.5 Daiichi-Sankyo Recent Developments
  79. 8.14 Astellas
  80. 8.14.1 Astellas Company Information
  81. 8.14.2 Astellas Business Overview
  82. 8.14.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  84. 8.14.5 Astellas Recent Developments
  85. 8.15 Ardelyx
  86. 8.15.1 Ardelyx Company Information
  87. 8.15.2 Ardelyx Business Overview
  88. 8.15.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  90. 8.15.5 Ardelyx Recent Developments
  91. 8.16 Akebia
  92. 8.16.1 Akebia Company Information
  93. 8.16.2 Akebia Business Overview
  94. 8.16.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolio
  96. 8.16.5 Akebia Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value Chain Analysis
  2. 9.1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Mode & Process
  6. 9.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors
  9. 9.2.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst